Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer (Q35758280)
Jump to navigation
Jump to search
scientific article published on 16 May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer |
scientific article published on 16 May 2005 |
Statements
1 reference
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer (English)
1 reference
Owen A O'Connor
1 reference
Howard Scher
1 reference
William Kevin Kelly
1 reference
Lee M Krug
1 reference
Judy H Chiao
1 reference
Mark Heaney
1 reference
Tracy Curley
1 reference
Barbara MacGregore-Cortelli
1 reference
William Tong
1 reference
J Paul Secrist
1 reference
Lawrence Schwartz
1 reference
Stacy Richardson
1 reference
Elaina Chu
1 reference
Semra Olgac
1 reference
Paul A Marks
1 reference
Victoria M Richon
1 reference
16 May 2005
1 reference
1 reference
23
1 reference
17
1 reference
3923-3931
1 reference
Identifiers
1 reference
1 reference
1 reference